J. Garcia-Garcia (Aviles, Spain), V. Melchionda (London, United Kingdom), A. Skrahina (Minsk Region, Belarus), I. Solovic (Vysne Hagy, Slovakia)
Latent tuberculosis in patients submitted to anti- TNF therapy – A retrospective study at a Santarem chest clinic
S. Silva, E. Tavares, M.G. Evaristo, J.M. Carvalho (Santarem, Portugal)
|   |
A comparison of on-site versus remote physician follow up of directly observed preventive treatment (DOPT) for latent tuberculosis infection (LTBI) on completion rates
H. Bishara, L. Ore, N. Armaly, D. Weiler Ravell (Nazareth, Haifa, Israel)
| |
Differences in the manegement of latent tuberculosis infection in patients treated with anti-TNF-α in Turkey
S. Ocal, N. Demir, S. Ataman, A. Ugur Demir, N. Suldur, A. Kaya, O. Kayacan (Ankara, Turkey)
| |
Particular aspects of TB endemia in Bucharest after adoption DOTS strategy
E. Tabacu, E. Ibraim, C. Didilescu (Bucharest, Craiova, Romania)
| |
Effectiveness of a tuberculosis screening program in rheumatic patients treated with immunossuppressants
J. Pimentel, C. Miguel, M. Grafino, T. Abreu, M. Felizardo, A. Teixeira, J. Vaz-Patto, M.C. Gomes (Lisbon, Portugal)
| |
Impact of the global economic crisis on the possible increase TB incidence in Serbia
M. Ilic, V. Kuruc, I. Kopitovic, S. Kasikovic Lecic (Sremska Kamenica, Republic Of Serbia)
| |
Childhood tuberculosis in Iasi County, Romania: 10 years review
V. Cojocariu, A. Sorete Arbore, R. Sorete Arbore (Iasi, Romania)
| |
Molecular epidemiology of multi drug resistance tuberculosis isolates from pulmonary tuberculosis cases from Lucknow, India
K. Srivastava, D.K. Tripathi, S. Kant, K.K. Srivastava (Lucknow, India)
| |
Resistance pattern to WHO category IV anti tuberculous drugs in patients suspected of multidrug resistance tuberculosis presenting to a specialist clinic in Maharashtra, India
P. Chhajed, A. Kate, H.S. Sandeep, P. Chaudhari, S. Subramanian, D. Miedinger, J. Leuppi, M. Tamm (Mumbai, India)
| |
Antituberculosis drug resistance rates in patients newly diagnosed with TB in Istanbul
O. Sezer, F. Ciftci, E. Bozkanat, T. Ozkisa, H. Kaya, T. Ursavas, Z. Kartaloglu (Ankara, Istanbul, Turkey)
| |
Drug sensitivity pattern (first line ATT) in DOTS failure & relapse cases (Cat I & Cat II) rntcp, India
G.N. Srivastava, M. Meena, P. Yadav, J. Meena, M. Hussain (Varanasi, India)
| |
Awareness about MDR-TB in private medical practitioners of Pune City
T. Sahasrabudhe, T. Joseph, S. Meshram, A. Pathak (Pimpri, Pune, India)
| |
Latent tuberculosis infection among close contacts of multidrugs-resistant tuberculosis patients in eastern Taiwan
C.B. Lin, J.J. Lee, H.W. Chou (Hualien, Taipei, Taiwan)
| |
Dynamics of MBT drug resistance in a specialized urban TB hospital (Saratov, Russia)
L. Pankratova, E. Pereselentseva, A. Filippov (Saratov, Russian Federation)
| |
Multidrug-resistant tuberculosis in the western region of Algeria
A. Ouardi, M. Hadjadj, Y. Berrabah (Oran, Tlemcen, Algeria)
| |
Risk factors of time to sputum smear conversion in multi-drugs resistant tuberculosis patients in Iran
P. Baghaei Shiva, M. Marjani, P. Tabarsi, M.R. Masjedi (Tehran, Islamic Republic Of Iran)
| |
The effectiveness of MDR TB treatment in children and adolescents depending on its duration
G. Bekembaeva, A. Alenova, L. Kastykpaeva (Almaty, Kazakhstan)
| |
The comparative analysis of treatment effectiveness in children and adolescents with MDR TB with anti-TB drugs of the first and second lines
T. Abildaev, G. Bekembaeva, L. Kastykpaeva (Almaty, Kazakhstan)
| |
Development of multi-drug resistant tuberculosis among patients treated with category II regimen: A lung center of the Philippines experience
S. Augusto, Jr, J. Gonong, L. Raymond, V. Lofranco (Quezon City, Philippines)
| |
Territorial distribution of multi-drug-resistant tuberculosis in Paraiba, Brazil
K.R.L. Figueiredo, V.L.A. Teotonio, A.B.M. Oliveira, G.S.D. Sousa, G.F.P. Winkeler, A.H. Medeiros-Neto (Joao Pessoa, Brazil)
| |